ANGELINI PHARMA SPA sell "FlowChem Platform"

Angelini API Business was among the first European CDMOs to invest in flow chemistry and micro-reaction technology for developing and manufacturing APIs and HPAPIs. Drawing on extensive R&D experience in continuous flow processes, it offers custom development, manufacturing technology, and related services. Equipped with a new R&D flow lab, a kilo-flow pilot-scale lab, and industrial continuous-flow reactors, its chemists and engineers support customers from R&D feasibility studies through proof-of-concept/proof-of-scalability work up to first mid-scale and commercial cGMP production, spanning roughly 1 kg to multi-ton output.